Karyopharm Announces Five Clinical Data Presentations at ASCO By: Benzinga via Benzinga April 22, 2014 at 07:10 AM EDT Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel ... Read More >> Related Stocks: Karyopharm Therapeut